Skip to main content
Ammar Al-Chalabi

Professor Ammar Al-Chalabi PhD FRCP FMedSci

Professor of Neurology and Complex Disease Genetics

Research interests

  • Neuroscience

Biography

I am a Professor of Neurology and Complex Disease Genetics at King’s College London where I am the Director of the King’s Motor Neuron Disease Care and Research Centre, and a consultant neurologist at King's College Hospital. My research focuses on causes, modifiers and potential treatments for ALS. I am co-Director of the UK MND Research Institute, Programme Chair of the International Symposium on ALS/MND, and a National Institute for Health Research Senior Investigator. I co-lead the Project MinE international whole genome sequencing initiative in ALS, and the MND Register of England, Wales and Northern Ireland.

My work has been recognized by multiple honours, including the Forbes Norris Award from the International Alliance of ALS/MND Associations, the Healey Center International Prize for Innovation in ALS, the Sheila Essey Award from the American Academy of Neurology, and Fellowship of the UK Academy of Medical Sciences. I am a Visiting Fellow at the Perron Institute for Neurological and Translational Science, and Lisa S Krivickas Visiting Professor at Massachusetts General Hospital. 

Please see my Research Staff Profile for more detail.

Key collaborators

  • Professor Leonard van den Berg, University Medical Center Utrecht
  • Professor Orla Hardiman, Trinity College Dublin
  • Professor Christopher McDermott, University of Sheffield
  • Professor Martin Turner, University of Oxford

Research

RHAPSODY Study
The RHAPSODY Study

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)

Project status: Ongoing

News

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government

The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

20240613 Perronvisit

Professor Ammar Al-Chalabi elected as Fellow of the Academy of Medical Sciences

Professor Ammar Al-Chalabi has been elected as a Fellow of the prestigious Academy for his remarkable contributions to advancing biomedical and health...

Prof-Ammar-Al-Chalabi

Three King's academics elected as Fellows of the Academy of Medical Sciences

Professors Ammar Al-Chalabi, Maddy Parsons and Jane Sandall have been elected as Fellows of the prestigious Academy in recognition of their industry-leading...

Academic Fellows

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

New research institute to accelerate the search for a cure for MND

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS), launches today in London.

Motor neuron

New programme to move potential MND drugs into clinical trials faster

A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease...

Research Lab

PrecisionLife completes data access agreement with King's College London to enable new precision neuroscience treatments and diagnostics in MND/ALS

The techbio company, PrecisionLife, announced that it has agreed a data access and licensing agreement with King’s College London to enable it to generate and...

A person at a laptop keyboard typing, you can only see their hands and the keyboard. A padlock logo is in the middle to show data protection.

Secretary of State for Health and Social Care visits King's College London

Following a meeting of sector leaders, the Rt Hon Stephen Barclay MP, Secretary of State for Health and Social Care, met with scientists from King’s College...

Steve Barclay Ammar Al-Chalabi

Treatment for Motor Neurone Disease shows promise

A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.

molecules

Research

RHAPSODY Study
The RHAPSODY Study

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)

Project status: Ongoing

News

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government

The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

20240613 Perronvisit

Professor Ammar Al-Chalabi elected as Fellow of the Academy of Medical Sciences

Professor Ammar Al-Chalabi has been elected as a Fellow of the prestigious Academy for his remarkable contributions to advancing biomedical and health...

Prof-Ammar-Al-Chalabi

Three King's academics elected as Fellows of the Academy of Medical Sciences

Professors Ammar Al-Chalabi, Maddy Parsons and Jane Sandall have been elected as Fellows of the prestigious Academy in recognition of their industry-leading...

Academic Fellows

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

New research institute to accelerate the search for a cure for MND

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS), launches today in London.

Motor neuron

New programme to move potential MND drugs into clinical trials faster

A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease...

Research Lab

PrecisionLife completes data access agreement with King's College London to enable new precision neuroscience treatments and diagnostics in MND/ALS

The techbio company, PrecisionLife, announced that it has agreed a data access and licensing agreement with King’s College London to enable it to generate and...

A person at a laptop keyboard typing, you can only see their hands and the keyboard. A padlock logo is in the middle to show data protection.

Secretary of State for Health and Social Care visits King's College London

Following a meeting of sector leaders, the Rt Hon Stephen Barclay MP, Secretary of State for Health and Social Care, met with scientists from King’s College...

Steve Barclay Ammar Al-Chalabi

Treatment for Motor Neurone Disease shows promise

A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.

molecules